이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Proof of Concept Study of EMBalance Decision Support System to Evaluate Balance Disorders (EMBalance)

2016년 10월 25일 업데이트: University College, London

A Decision Support System Incorporating a Validated Patient-specific, Multi-scale Balance Hyper Model Towards Early Diagnostic Evaluation and Efficient Management Plan Formulation of Balance Disorders (EMBalance)

Balance is crucial for an individual's mobility and independence. Human balance is achieved and maintained by a complex set of sensorimotor systems that include sensory input from vision, proprioception and the vestibular system (motion, equilibrium, spatial orientation). This information is then integrated by the brain. This complexity leads to undiagnosed or mistreated patients with balance disorders for long period which can affect their daily activities.

The EMBalance project is a research project funded by the European Union, involving 10 universities across Europe. Its aim is to create a Decision Support System (DSS) to support doctors in diagnosing and treating balance disorders. It will be available to primary and secondary care doctors of different specialties, levels of training and in different parts of the country.

The DSS will:

  • Be used by primary and secondary health care professionals
  • Assist the doctor on the evaluation and management of dizzy patients
  • Predict how the balance disorder may progress
  • Reduce patient waiting time and the onward referrals
  • Ensure patients receive prompt and efficient treatment plans

The EMBalance randomised clinical trial (RCT) is a proof-of-concept, multicentre, single-blind, and parallel group study, conducted in Belgium, Germany, Greece and United Kingdom. At present, the question that this study aims to answer is whether the algorithms developed for the EMBalance Platform will yield meaningful information and how these algorithms and platform can be improved, performing an offline comparison of the classical diagnostic approach and the outcome of the EMBalance platform, without any consequence for the patient.

Patients who present with balance related symptoms at primary care will be randomised to either intervention group (non-specialist doctor +DSS) or control group (non-specialist doctor -DSS). An overseeing expert will then confirm the diagnosis and management decisions made by the non-specialist doctors in order to determine whether the use of the DSS can help them in a more precise assessment.

연구 개요

상세 설명

Balance is crucial for an individual's mobility and independence. Dizziness and imbalance symptoms are one of the most common reasons for visits to a doctor and affect up to 30-40% of the population by 60 years of age. The healthcare service provision to address vestibular pathology remains inadequate and is regarded as low priority. The complexity of balance control mechanisms, the lack of medical expertise, and the absence of specialised equipment can be contributory factors to the mismanagement of patients suffering balance disorders. However, the mean number for patient visits to their Health Care providers required to establish a correct diagnosis and start appropriate treatment, both in the US and the UK, is 4.5. The overall socio-economic impact of balance disorders on the affected individual, patient's families as well as the burden on society and the health services is considerable.

Advances in computer science and artificial intelligence have allowed the development of computer systems that support clinical diagnosis or therapeutic and treatment decisions based on individualised patient data. However, a review of existing Decision Support Systems used in Medicine demonstrated there are not many successful integrated software systems or standalone tools that address the early diagnosis and effective management of balance disorders.

All this said, the EMBalance DSS has been developed as a supplementary and supportive tool for non-expert physicians faced with the challenge of addressing vestibular disorders.

The current study will assess the effectiveness of the EMBalance Decision Support System (DSS) for diagnosis and management of balance disorders in a feasibility/proof of concept study. Patients who present with balance related symptoms (specifically vertigo or dizziness exacerbated by head movements) in primary care, will be seen by a non-specialist doctor either with or without the support of the DSS, on a ratio 1:1.

Non-specialist doctors in each participating country are defined as follow:

  • UK: General Practitioners
  • Germany: Neurology residents
  • Belgium & Greece: ENT residents

Overseeing experts in each participating country are defined as follow:

  • UK: Consultant in audiovestibular medicine (AVM)
  • Germany: Neurologist
  • Belgium & Greece: ENT specialist with >10 years expertise in AVM/Neuro-otology

It is anticipated 100 participants will be recruited to each of the two treatment groups, giving a total of 200 participants across Europe. Each participating site in Greece, Belgium, Germany and United Kingdom will recruit 50 patients. Allocation will be performed based on randomisation tables that are produced in advance for each centre.

Statistical data analysis will be performed by the National and Kapodistrian University of Athens. The statistical analysis has been developed by the National and Kapodistrian University of Athens and reviewed by the Institute of Communication and Computer Science (Greece).

Quality and ethical assurance are supervised by the Trial Steering Committee (TSC) and Trial Management Group (TMG)

연구 유형

중재적

등록 (실제)

200

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

      • Athens, 그리스, 115 27
        • Hippocrateio Hospital
      • Freiburg, 독일, 79106
        • Freiburg University Medical Center
      • Edegem, 벨기에, 2650
        • Antwerp University Hospital

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

18년 (성인, 고령자)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

설명

Inclusion Criteria:

  • Be capable of understanding the information provided
  • Absence of dementia/uncontrolled psychiatric disorder
  • Vertigo or chronic dizziness exacerbated by head movements (<12 months)
  • Sub-acute presentation of dizziness (up to 3 months) without presenting to emergency services

Exclusion Criteria:

  • Subjects with learning disability or dementia
  • Patients with uncontrolled psychiatric disorders
  • Pregnant and breastfeeding women
  • Patients' incapable or unwilling to give informed consent.
  • Patients with acute vestibular disorders (present at Accident and Emergency).

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 특수 증상
  • 할당: 무작위
  • 중재 모델: 병렬 할당
  • 마스킹: 하나의

무기와 개입

참가자 그룹 / 팔
개입 / 치료
실험적: Non-specialist doctor +DSS

Patients allocated to +DSS group will receive the following intervention:

  • V1: appointment with a non-specialist doctor with the support of the DSS
  • V2: appointment with an overseeing expert
  • V3: DSS Customised Vestibular Physiotherapy
  • V4: follow-up visit with the overseeing expert

The EMBalance DSS is a program which summarises and structures clinical information. The structuring of medical information is based on algorithms that have been developed and are employed via the DSS platform. The non-specialist doctors who use the DSS will be asked to exercise their clinical judgement in order to come up with a diagnosis or management plan. The DSS use has the following characteristics:

  1. Doctors can pace the process anyway they see fit (e.g. by switching from history taking to examination, stopping at any point, or going back to medical history) or by stopping the process entirely.
  2. Although the EMBalance platform will propose 2-3 diagnosis (with probability estimation for each), doctors will be asked to either choose one of these or discard and choose their own.
다른 이름들:
  • Decision Making Software
After the initial appointment with the non-specialist doctor, all patients will be invited to attend a specialist neuro-otology clinic where they will be seen by an overseeing expert in order to undergo a "Gold Standard" diagnostic process, and determine the management plan appropriate to the diagnosis, which will be compared to the management plan previously advised by the non-specialist doctor. The overseeing expert will review investigations carried out, results assessed by the non-specialist doctor.

Customised vestibular exercise programme suggested by the DSS. Such exercises are based on the eye, head, and postural exercises that provoke a patient's symptoms.

  1. Adaptation exercises incorporating gaze fixation and head movements and postural exercises are prescribed to promote recovery of the vestibule-ocular reflex (VOR) and vestibulo-spinal reflex function. Up to 5 exercises will be practised by the patient at home for approximately 1-2 minutes each, twice daily initially at a slow speed which gradually increases as symptoms improve.
  2. Patients presenting vestibular migraine will perform a maximum of three exercises. These exercises will be chosen by the DSS from a range of established exercises and chosen according to the patient's symptoms when performing the exercise/type of movement.
다른 이름들:
  • 전정 재활
All patients will be reviewed after three months follow-up by the overseeing expert.
활성 비교기: Non-specialist doctor -DSS

Patients allocated to -DSS group will receive the following intervention:

  • V1: appointment with a non-specialist doctor without the support of the DSS
  • V2: appointment with an overseeing expert
  • V3: Standard Physiotherapy Practice
  • V4: follow-up visit with the overseeing expert
After the initial appointment with the non-specialist doctor, all patients will be invited to attend a specialist neuro-otology clinic where they will be seen by an overseeing expert in order to undergo a "Gold Standard" diagnostic process, and determine the management plan appropriate to the diagnosis, which will be compared to the management plan previously advised by the non-specialist doctor. The overseeing expert will review investigations carried out, results assessed by the non-specialist doctor.
All patients will be reviewed after three months follow-up by the overseeing expert.
Patient will be referred to a local physiotherapy service by his/her non-specialist doctor within 18 weeks from referral. Standard vestibular rehabilitation practice consists of a customised exercise programme, this is service dependent and tailored for patient's symptoms. The rehabilitation programme might include lifestyle advice and education, sometimes accompanied by a leaflet.
다른 이름들:
  • Standard Rehabilitation Practice

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Percentage of diagnosis agreement
기간: Through study completion, an average of 8 months
Agreement between the diagnosis established by the non-specialist doctors (using the DSS and not using DSS) and the "Gold Standard" as determined by an overseeing expert and according to current evidence based guidelines for the diagnosis/management of these disorders.
Through study completion, an average of 8 months
Percentage of management plan agreement
기간: Through study completion, an average of 8 months
Agreement between the management plan established by the non-specialist doctors (using the DSS and not using DSS) and the "Gold Standard" as recommended by an overseeing expert and according to current evidence based guidelines for the diagnosis/management of these disorders.
Through study completion, an average of 8 months

2차 결과 측정

결과 측정
기간
Number of initial diagnoses changed after investigations proposed
기간: Through study completion, an average of 8 months
Through study completion, an average of 8 months
Number of referrals to secondary care needed
기간: Through study completion, an average of 8 months
Through study completion, an average of 8 months
Name of investigations required for an accurate diagnosis
기간: Through study completion, an average of 8 months
Through study completion, an average of 8 months
Overall improvement according to the patient (Better, stable, worse)
기간: Change from baseline at 3 months (follow-up)
Change from baseline at 3 months (follow-up)
Overall improvement according to overseeing expert (Better, stable, worse)
기간: Change from baseline at 3 months (follow-up)
Change from baseline at 3 months (follow-up)
Severity of symptoms (Visual Analogue Scale from 1-10 (VAS))
기간: Change from baseline at 3 months (follow-up)
Change from baseline at 3 months (follow-up)
Difficulties regarding dizziness (Dizziness Handicap Inventory questionnaire (DHI))
기간: Change from baseline at 3 months (follow-up)
Change from baseline at 3 months (follow-up)
Quality of life (EQ-5D-3L Questionnaire)
기간: Change from baseline at 3 months (follow-up)
Change from baseline at 3 months (follow-up)
Number of patients not enrolled and/or withdrawn from the trial
기간: Through study completion, an average of 8 months
Through study completion, an average of 8 months
Reason for exclusion to the trial
기간: Through study completion, an average of 8 months
Through study completion, an average of 8 months

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

수사관

  • 수석 연구원: Doris-Eva Bamiou, MD MSc FRCP PhD, University College, London
  • 연구 책임자: Linda M Luxon, CBE BSc FRCP FRCPE, Royal College of Physicians

간행물 및 유용한 링크

연구에 대한 정보 입력을 담당하는 사람이 자발적으로 이러한 간행물을 제공합니다. 이것은 연구와 관련된 모든 것에 관한 것일 수 있습니다.

일반 간행물

유용한 링크

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작

2016년 3월 1일

기본 완료 (실제)

2016년 9월 1일

연구 완료 (실제)

2016년 9월 1일

연구 등록 날짜

최초 제출

2016년 2월 29일

QC 기준을 충족하는 최초 제출

2016년 3월 4일

처음 게시됨 (추정)

2016년 3월 10일

연구 기록 업데이트

마지막 업데이트 게시됨 (추정)

2016년 10월 26일

QC 기준을 충족하는 마지막 업데이트 제출

2016년 10월 25일

마지막으로 확인됨

2016년 2월 1일

추가 정보

이 연구와 관련된 용어

기타 연구 ID 번호

  • 13/0336
  • 610454 (기타 보조금/기금 번호: EU Seventh Framework Programme)

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

아니요

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다